These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12587783)

  • 1. Diagnostic value of C-reactive protein in patients with angiographically documented coronary heart disease.
    Eren E; Yilmaz N; Pence S; Kocoglu H; Göksu S; Kocabaş R; Kadayifci S
    Acta Medica (Hradec Kralove); 2002; 45(4):155-60. PubMed ID: 12587783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.
    Pu LJ; Lu L; Xu XW; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Lou S; Shen J; Fang DH; Shen WF
    Cardiovasc Diabetol; 2006 Dec; 5():27. PubMed ID: 17178005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein as a predictor for poor collateral circulation in patients with chronic stable coronary heart disease.
    Fan Y; Li S; Li XL; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Dong Q; Liu G; Li JJ
    Ann Med; 2016; 48(1-2):83-8. PubMed ID: 26790524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease.
    Haidari M; Javadi E; Sadeghi B; Hajilooi M; Ghanbili J
    Clin Biochem; 2001 Jun; 34(4):309-15. PubMed ID: 11440732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of CRP and Lp(a) in coronary heart disease.
    Erbağci AB; Tarakçioğlu M; Aksoy M; Kocabaş R; Nacak M; Aynacioğlu AS; Sivrikoz C
    Acta Cardiol; 2002 Jun; 57(3):197-204. PubMed ID: 12088177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein elevation and disease activity in patients with coronary artery disease.
    Arroyo-Espliguero R; Avanzas P; Cosín-Sales J; Aldama G; Pizzi C; Kaski JC
    Eur Heart J; 2004 Mar; 25(5):401-8. PubMed ID: 15033252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.
    Alber HF; Wanitschek MM; de Waha S; Ladurner A; Suessenbacher A; Dörler J; Dichtl W; Frick M; Ulmer H; Pachinger O; Weidinger F
    Eur J Clin Invest; 2008 Jun; 38(6):372-80. PubMed ID: 18489399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of circulating matrix metalloproteinase-1, but not adiponectin, with advanced coronary artery disease.
    Hwang JJ; Yang WS; Chiang FT; Chen MF; Lin HJ; Huang PJ; Hsu SH; Lai SK; Wu YW
    Atherosclerosis; 2009 May; 204(1):293-7. PubMed ID: 18823886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
    Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
    J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A relationship between CRP, adiponectin and Gensini score in the patients with coronary artery disease].
    Dursunoğlu D; Göksoy H; Oztürk M; Rota S
    Anadolu Kardiyol Derg; 2011 May; 11(3):195-200. PubMed ID: 21421513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of plasma intermedin levels in patients who underwent first-time diagnostic coronary angiography: a single centre, cross-sectional study.
    Yamac AH; Bacaksiz A; Ismailoglu Z; Kucukbuzcu S; Sevgili E; Asoglu E; Nasifov M; Jafarov P; Erdogan E; Goktekin O
    BMC Cardiovasc Disord; 2014 Dec; 14():182. PubMed ID: 25495100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease.
    Yilmaz N; Ciçek HK; Celik A; Meram I; Kocabas R; Davutoglu V
    East Mediterr Health J; 2007; 13(3):522-35. PubMed ID: 17687824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease.
    Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B
    Indian Heart J; 2002; 54(3):284-8. PubMed ID: 12216925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of serum cystatin C in predicting coronary artery disease.
    Koc M; Batur MK; Karaarslan O; Abali G
    Cardiol J; 2010; 17(4):374-80. PubMed ID: 20690093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.